Consumers and Employees Call for a New Approach to Corporate Philanthropy: Stakeholder Philanthropy
Four in five consumers (84%) and employees (86%) believe that stakeholders should have a say in how a business allocates charitable funds
CALGARY, Alberta, May 17, 2022 (GLOBE NEWSWIRE) -- Benevity Inc., a leading provider of global corporate purpose software, today released results of a new survey measuring public sentiment on corporate philanthropy. The findings highlight a growing interest in and expectation of employees and consumers to be involved in corporate philanthropy and call on businesses to consider a new approach that is more stakeholder driven. Businesses that evolve toward this new model of stakeholder philanthropy will benefit financially, with respondents saying they are more likely to buy from, work for and stay with companies who engage them.
Benevity’s Engagement in Corporate Giving study found that four of five consumers (84%) and employees (86%) believe they should be able to have a say in how a business allocates its charitable funds. Additionally, 73% of consumers would purchase from a business and 78% of employees would work for a business if it sought their input into the charitable causes it supports. Furthermore, 84% of consumers and 85% of employees say the more a business engages its consumers and employees in charitable giving decisions, the more trust they have in that business.
“Corporate philanthropy is the longest-standing way that businesses have given back, but there is a re-imagining happening in the wake of stakeholder capitalism,” said Sona Khosla, Benevity’s Chief Impact Officer. “Brands who choose to engage stakeholders — notably employees and customers — in their corporate philanthropy strategies have a clear opportunity to create a more trusted relationship, helping to attract and engage today’s purpose-driven talent and customers.”
Over the past two years, stakeholders have become more invested in where and how corporate philanthropy is distributed and are calling for a more empowered, inclusive grassroots approach in which diverse groups — including employees, customers, local community members, partners and investors — are engaged in the decision-making regarding the allocation of corporate charitable funds to communities and nonprofits.
Key Survey Findings
Stakeholders want a voice
- 82% of consumers and 85% of employees say they frequently have no say or involvement in the organizations supported by the companies from whom they purchase from or work for.
- 84% of consumers and 86% of employees believe that stakeholders, including customers and employees, should be able to have a say in how a business allocates its charitable funds. Of the 84% of consumers, almost 50% feel very strongly about this.
- 78% of consumers and 80% of employees are likely to provide input into the organizations a business supports if given the opportunity.
Transparency and trust
- 32% of consumers and 39% of employees are interested in where companies are allocating charitable funds.
- Interest is even stronger (44%) among those who live near the headquarters of major brands and companies.
- 84% of consumers agree that the more a business engages its consumers and employees in its decisions on charitable giving, the more trust consumers have in that business.
Employee engagement and retention
- 78% of employees are likely to work for an organization who provides transparency into how it allocates its charitable donations.
Impact on bottom line
- 73% of consumers say they would be likely to use or shop with a business who seeks their input on the charitable causes it supports.
“As stakeholder capitalism takes root, stakeholder philanthropy is clearly emerging as a new trend in corporate giving. Corporations are being asked to engage a variety of stakeholders to make corporate giving more democratized and authentic than ever before,” added Khosla.
About the survey: Wakefield conducted the survey, Engagement in Corporate Giving: How Companies Can Involve Consumers and Employees in Financial Donations, on behalf of Benevity between February 25 and March 6, 2022. The survey asked 1,000 North American adults their thoughts on corporate philanthropy, including community investment and granting, and how a greater impact can be made.
Benevity, a certified B Corporation, is a leader in global corporate purpose software, providing the only integrated suite of community investment and employee, customer and nonprofit engagement solutions. Recognized as one of Fortune’s Impact 20, Benevity offers cloud solutions that power purpose for many iconic brands in ways that better attract, retain and engage today’s diverse workforce, embed social action into their customer experiences and positively impact their communities. With software that is available in 22 languages, Benevity has processed more than $8 billion in donations and 43 million hours of volunteering time to support 326,000 nonprofits worldwide. The company’s solutions have also facilitated 530,000 positive actions and awarded 1.2 million grants worth $12 billion. For more information, visit benevity.com.
Senior Manager Public Relations
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 202224.6.2022 22:05:00 CEST | Press release
REPORT –ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022 Cambridge, MA (U.S.) and Lyon (France), June24, 2022 – ERYTECH Pharma (Nasdaq& Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announcedthat its Annual General Meeting was held on Friday, June 24, 2022. At the meeting, all resolutions for which the Board of Directors recommended a vote in favor were adopted, including: Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2021;Allocation of the financial year's results;Approval of the statutory auditors’ special report on regulated agreements and commitments with related parties;Approval of the elements of total compensation and benefits paid or allocated for the year ended December 31, 2021, to Gil BEYEN, Chief Executive Officer and Jean-Paul KRESS, Chairman of the Board;Approval of the compens
Cleantech Building Materials: Results of Annual General Meeting24.6.2022 14:54:27 CEST | Press release
24 June 2022 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER: CBM ISIN: GBOOBD1LVD21 CLEANTECH BUILDING MATERIALS PLC Results of Annual General Meeting The Annual General Meeting (“AGM”) of Cleantech Building Materials plc (“CBM” or the “Company”) was held in London earlier today, 24 June 2022. Details of the resolutions to be considered at the AGM were published in the Notice of AGM which was posted to Shareholders on 1 June 2022 and is available on the Company’s website: www.cbm-plc.com. All resolutions as set out in the Notice of AGM were duly passed without discussion. In particular, the following resolutions were passed at the AGM. The AGM resolved to authorise the directors of the Company to allot shares and grant rights to subscribe for, or convert any security, into shares. The directors of the Company sought authority for the purposes of section 551 of the Companies Act to exercise all the powers of the Company to allot shares and grant ri
Novartis receives positive CHMP opinion for Scemblix®, a novel treatment for adult patients with chronic myeloid leukemia24.6.2022 13:13:19 CEST | Press release
With unique STAMP mechanism of action, Scemblix could provide a new option for patients in Europe with chronic myeloid leukemia (CML) who have suffered intolerance or inadequate response with at least two prior tyrosine kinase inhibitor treatments1 Positive opinion based on data from pivotal Phase III ASCEMBL trial, showing a near doubling in major molecular response rate for patients treated with Scemblix® (asciminib) vs. Bosulif®* (bosutinib) (25.5% vs. 13.2%) and more than three times lower discontinuation rate due to adverse reactions (5.8% vs 21.1%) at 24 weeks1 CHMP recommendation comes after the approval of Scemblix by the US FDA and other countries’ regulatory authorities, potentially broadening access for more patients to Novartis transformative therapies in CML Basel, June 24, 2022 — Novartis today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing au
Clariant’s shareholders approve all agenda items24.6.2022 11:30:00 CEST | Press release
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Integrated Report and Group Consolidated Financial Statements for fiscal year 2021 approvedGünter von Au reelected as Chairman of the Board of DirectorsThree new candidates join the Board of Directors: Ahmed Mohamed Alumar, Roberto César Gualdoni, Naveena ShastriConfirmed distribution of CHF 0.40 per shareKPMG confirmed as statutory auditor from 2022 MUTTENZ, JUNE 24, 2022 Clariant, a focused, sustainable, and innovative specialty chemical company, today held its 27th Annual General Meeting (AGM) where the shareholders approved all agenda items and resolutions as proposed by the Board of Directors. The AGM was held virtually, where shareholders were able to exercise their rights exclusively via the independent proxy. Overall, 698'945'298 shares or around 70.19 % of the share capital of Clariant were represented. Günter von Au was reelected as Chairman of the Board of Directors. Additionally, three new members were voted to join by a large majo
Cool Company Ltd. – Mandatory Notification Of Trade24.6.2022 11:01:19 CEST | Press release
EPS Ventures Ltd., close associate of Cyril Ducau, Chair of the Board of Cool Company Ltd. (the “Company”), has on 23 June 2022 acquired 7,865 shares in the Company at a price of NOK 90.274882 per share. Following the transaction, EPS Ventures Ltd. holds a total of 15,591,218 shares in the Company, equivalent to 38.97% of the Company’s shares. Please see the attached notification form in accordance with the Market Abuse Regulation article 19. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Primary insider notification form